- Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
-
Kamrul-Hasan A, Alam MS, Talukder SK, Dutta D, Selim S
- KMID: 2552803
- Endocrinol Metab.
- 2024 Feb;39(1):109-126.
- doi: 10.3803/EnM.2023.1839
Background: No recent meta-analysis has holistically analyzed and summarized the efficacy and safety of omarigliptin in type 2 diabetes mellitus (T2DM). We conducted a meta-analysis to address this knowledge gap. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- South Asian Working Action Group on SARCOpenia (SWAG-SARCO) e A consensus document
-
Dhar M, Kapoor N, Suastika K, Khamseh ME, Selim S, Kumar V, Raza SA, Azmat U, Pathania M, Mahadeb YPR, Singhal S, Naseri MW, Aryana IS, Thapa SD, Jacob J, Somasundaram N, Latheef A, Dhakal GP, Kalra S
- KMID: 2537730
- Osteoporos Sarcopenia.
- 2022 Jun;8(2):35-57.
- doi: 10.1016/j.afos.2022.04.001
The South Asian population is rapidly ageing and sarcopenia is likely to become a huge burden in this region if proper action is not taken in time. Several sarcopenia guidelines... -
- CITED
-
- Close
- SHARE
-
- Close
